252 related articles for article (PubMed ID: 6365808)
1. Comparison of sustained-release and standard preparations of clonidine in essential hypertension.
Fyhrquist F
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):634-6. PubMed ID: 6365808
[TBL] [Abstract][Full Text] [Related]
2. Sustained release metoprolol: a comparison with conventional formulation in the treatment of hypertension.
Logan RL; Goldstraw PW; Kiddle GB; Flacks LM; Watt M
N Z Med J; 1981 Jul; 93(687):1-2. PubMed ID: 7022275
[TBL] [Abstract][Full Text] [Related]
3. Clonidine twice daily in hypertension. Effects of two dosage regimens on blood pressure, side-effects and plasma clonidine concentrations.
Lilja M; Huikuri H; Jounela AJ; Juustila HJ; Paalzow G
Acta Med Scand; 1983; 214(2):111-7. PubMed ID: 6353878
[TBL] [Abstract][Full Text] [Related]
4. [A new antihypertensive agent used in a clinical setting].
Wetzels E; Raschig A; Kaiser HJ
Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive efficacy of sustained-release verapamil.
Zachariah PK; Sheps SG; Oshrain C; Schirger A; Stein WJ
J Clin Hypertens; 1987 Dec; 3(4):536-46. PubMed ID: 3330987
[TBL] [Abstract][Full Text] [Related]
6. [Duration of effectiveness of clonidine-depot: a double-blind trial (author's transl)].
Steger W
Dtsch Med Wochenschr; 1980 Jun; 105(26):928-30. PubMed ID: 6996986
[TBL] [Abstract][Full Text] [Related]
7. Transdermal clonidine in mild hypertension. A randomized, double-blind, placebo-controlled trial.
Popli S; Daugirdas JT; Neubauer JA; Hockenberry B; Hano JE; Ing TS
Arch Intern Med; 1986 Nov; 146(11):2140-4. PubMed ID: 3535714
[TBL] [Abstract][Full Text] [Related]
8. A double blind comparison of indoramin with clonidine in the treatment of moderate to severe essential hypertension.
Yajnik BH; Shah JS
J Assoc Physicians India; 1985 May; 33(5):339-43. PubMed ID: 3900029
[No Abstract] [Full Text] [Related]
9. Antihypertensive effect of N-amidino-2-(2,6-dichlorophenyl) acetamide hydrochloride. A double-blind cross-over trial versus clonidine.
Kirch W; Distler A
Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):132-5. PubMed ID: 348614
[TBL] [Abstract][Full Text] [Related]
10. A clinical study on the prolonged antihypertensive effect of clonidine in a sustained-release capsule formulation.
Martens V; Bentsen P; Hochrein H
Pharmatherapeutica; 1980; 2(7):456-61. PubMed ID: 7208540
[TBL] [Abstract][Full Text] [Related]
11. Clonidine and prazosin in the treatment of hypertensive outpatients--a preliminary study.
González-Gómez A; Díaz Novás J; Gamio Capestany F; Rodríguez de la Vega A; García-Barreto D
Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):524-8. PubMed ID: 6642791
[TBL] [Abstract][Full Text] [Related]
12. Clonidine in mild to moderate hypertension: effects on blood pressure and serum lipoproteins.
Karlberg BE; Lins LE; Rössner S
J Hypertens Suppl; 1985 Dec; 3(4):S69-71. PubMed ID: 3913756
[TBL] [Abstract][Full Text] [Related]
13. Safety aspects of long-term antihypertensive therapy (10 years) with clonidine.
Ferder L; Inserra F; Medina F
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S104-8. PubMed ID: 2455159
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-term administration of clonidine on plasma renin activity.
De Wurstemberger B; Gysling E
Can Med Assoc J; 1976 Dec; 115(11):1107-8. PubMed ID: 1000443
[TBL] [Abstract][Full Text] [Related]
15. Clonidine through the skin in the treatment of essential hypertension: is it practical?
Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W
J Hypertens Suppl; 1983 Dec; 1(2):120-2. PubMed ID: 6599488
[TBL] [Abstract][Full Text] [Related]
16. [Comparative double-blind, randomized, crossover study controlled with placebo, of the efficacy of depot nifedipine in patients refractory to basic antihypertensive therapy].
Bozza AE; Guimarães FJ; de Carvalho FJ; Santos LC; Pellon FM; de Castro RF; Balbuena RR
Arq Bras Cardiol; 1984 Sep; 43(3):213-7. PubMed ID: 6398994
[No Abstract] [Full Text] [Related]
17. One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators.
Clin Auton Res; 1993 Dec; 3(6):379-83. PubMed ID: 8193525
[TBL] [Abstract][Full Text] [Related]
18. [Clonidine transdermal therapeutic system in essential hypertension: effect and tolerance].
Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W
Schweiz Med Wochenschr; 1983 Dec; 113(49):1841-5. PubMed ID: 6676936
[TBL] [Abstract][Full Text] [Related]
19. Clonidine in primary hypertension: effects on blood pressure, plasma renin activity, plasma and urinary aldosterone.
Karlberg BE; Nilsson O; Tolagen K
Curr Ther Res Clin Exp; 1977 Jan; 21(1):10-20. PubMed ID: 401703
[No Abstract] [Full Text] [Related]
20. Long-term safety and efficacy comparison of immediate-release and sustained-release oral verapamil in systemic hypertension.
Frishman WH; Eisen G; Charlap S; Strom JA
J Clin Hypertens; 1987 Dec; 3(4):605-9. PubMed ID: 3134517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
